Cite

HARVARD Citation

    Diéras, V. et al. (2019). Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer. Journal of the National Cancer Institute. pp. 419-430. [Online]. 
  
Back to record